Showing results (1901-1910 of 1,947) with videos related to

Sort By:
Pageof 195
Bjpsych Open|August 18, 2025
Breaking stigma, discrimination and promoting rights: global evaluation of the World Health Organization QualityRights e-training on mental health, recovery and community inclusionMichelle Funk, Natalie Drew Bold, Charity Muturi, et al.
Physical Review Letters|April 13, 2019
First Observation of Unbound ^{11}O, the Mirror of the Halo Nucleus ^{11}LiT B Webb, S M Wang, K W Brown, et al.
Nature Communications|April 21, 2022
Neutron-upscattering enhancement of the triple-alpha processJ Bishop, C E Parker, G V Rogachev, et al.
International Journal of Neonatal Screening|February 28, 2022
Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass SpectrometryCarmencita D Padilla, Bradford L Therrell, Maria Melanie Liberty B Alcausin, et al.
BMC Public Health|January 26, 2026
Exploring and enhancing community awareness on antimicrobial resistance: perspectives from world antimicrobial resistance awareness week celebration in GhanaAloysius Dzigbordi Loglo, Michael Nkrumah-Appau, James Deke, et al.
European Journal of Heart Failure|March 9, 2026
Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEFAmiya A Ahmed, Frederick Lu, Sijian Zhang, et al.
The Journal of Cell Biology|December 23, 2009
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosomeLeslie Michels Thompson, Charity T Aiken, Linda S Kaltenbach, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)Kyle A Emmitte, Brian J Wilson, Erich W Baum, et al.
Physical Review Letters|January 14, 2022
First Observation of the Four-Proton Unbound Nucleus ^{18}MgY Jin, C Y Niu, K W Brown, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Pageof 195